Edition:
United States

MEDNAX Inc (MD.N)

MD.N on New York Stock Exchange

37.08USD
10:20am EST
Change (% chg)

$-0.45 (-1.20%)
Prev Close
$37.53
Open
$37.41
Day's High
$37.41
Day's Low
$37.08
Volume
12,605
Avg. Vol
245,502
52-wk High
$62.75
52-wk Low
$37.08

Latest Key Developments (Source: Significant Developments)

Mednax Announces Completion Of $250 Mln Share Repurchase Program
6:45am EST 

Dec 14 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES COMPLETION OF $250 MILLION ACCELERATED SHARE REPURCHASE PROGRAM.MEDNAX INC - AS OF DECEMBER 13, 2018, APPROXIMATELY $250 MILLION WAS REMAINING UNDER PREVIOUS AUTHORIZATION..  Full Article

Mednax Radiology Solutions Launches Artificial Intelligence Incubator
Tuesday, 27 Nov 2018 06:45am EST 

Nov 27 (Reuters) - MEDNAX Inc ::MEDNAX RADIOLOGY SOLUTIONS LAUNCHES ARTIFICIAL INTELLIGENCE INCUBATOR.  Full Article

Mednax Announces Pricing Of $500 Mln Of Senior Notes
Wednesday, 7 Nov 2018 07:02pm EST 

Nov 7 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES PRICING OF $500 MILLION OF 6.250% SENIOR NOTES DUE 2027.PRICING OF $500 MILLION AGGREGATE PRINCIPAL AMOUNT OF ITS 6.250% SENIOR NOTES DUE JANUARY 15, 2027.  Full Article

Mednax launches private offering of $750 mln senior notes due 2026
Wednesday, 7 Nov 2018 07:40am EST 

Nov 7 (Reuters) - MEDNAX Inc ::MEDNAX LAUNCHES PRIVATE OFFERING OF $750 MILLION SENIOR NOTES DUE 2026.MEDNAX INC - INTENDS TO USE PROCEEDS TO REPAY A PORTION OF INDEBTEDNESS OUTSTANDING UNDER ITS SENIOR UNSECURED REVOLVING CREDIT FACILITY.  Full Article

Mednax Reports Third Quarter 2018 Results
Thursday, 1 Nov 2018 06:00am EDT 

Nov 1 (Reuters) - MEDNAX Inc ::MEDNAX REPORTS THIRD QUARTER GAAP EPS OF $0.72; ADJUSTED EPS OF $0.94.SEES Q4 2018 ADJUSTED EARNINGS PER SHARE $0.87 TO $0.95.SEES Q4 2018 EARNINGS PER SHARE $0.65 TO $0.73.Q3 ADJUSTED EARNINGS PER SHARE $0.94.Q3 EARNINGS PER SHARE $0.72.Q3 REVENUE $897 MILLION VERSUS I/B/E/S VIEW $908 MILLION.Q3 SAME STORE SALES ROSE 1.2 PERCENT.Q3 EARNINGS PER SHARE VIEW $0.96 -- THOMSON REUTERS I/B/E/S.ANNOUNCES INITIATION OF PROCESS TO SELL MEDDATA.IS INITIATING A PROCESS TO POTENTIALLY SELL MEDDATA, COMPANY'S MANAGEMENT-SERVICES ORGANIZATION.MEDNAX - CURRENTLY INTENDS TO USE PROCEEDS FROM A POTENTIAL TRANSACTION FOR MEDDATA TO FUND SHARE REPURCHASES, DEBT REPAYMENT, AND FUTURE ACQUISITIONS.TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDING DECEMBER 31, 2018 WILL BE IN A RANGE OF FLAT TO TWO PERCENT.  Full Article

Mednax Announces Acquisition Of Leading Tennessee Radiology Practice
Thursday, 1 Nov 2018 05:55am EDT 

Nov 1 (Reuters) - MEDNAX Inc ::MEDNAX ANNOUNCES ACQUISITION OF LEADING TENNESSEE RADIOLOGY PRACTICE.MEDNAX INC - NO ADDITIONAL TERMS OF TRANSACTION WERE DISCLOSED..MEDNAX INC - WAS A CASH TRANSACTION AND IT IS EXPECTED TO BE IMMEDIATELY ACCRETIVE TO EARNINGS.MEDNAX INC - EIGHT PHYSICIAN GROUP PRACTICES HAVE BECOME PART OF MEDNAX IN 2018.MEDNAX INC - BUYS ASSOCIATES IN DIAGNOSTIC RADIOLOGY, P.C..  Full Article

Mednax Appoints Stephen Farber As Executive Vice President, To Succeed CFO
Thursday, 23 Aug 2018 06:45am EDT 

Aug 23 (Reuters) - MEDNAX Inc ::MEDNAX APPOINTS STEPHEN D. FARBER AS EXECUTIVE VICE PRESIDENT, TO SUCCEED CHIEF FINANCIAL OFFICER.MEDNAX INC - APPOINTMENT OF STEPHEN D. FARBER AS EXECUTIVE VICE PRESIDENT, EFFECTIVE AUGUST 27, 2018.MEDNAX INC - FARBER WILL ASSUME ADDITIONAL ROLE OF CHIEF FINANCIAL OFFICER IN NOVEMBER 2018.MEDNAX INC - FARBER TO SUCCEED VIVIAN LOPEZ-BLANCO, WHO RECENTLY ANNOUNCED HER PLANNED RETIREMENT FROM COMPANY.  Full Article

Mednax Reports Second Quarter GAAP EPS Of $0.85 Adjusted EPS Of $1.07
Thursday, 2 Aug 2018 06:00am EDT 

Aug 2 (Reuters) - MEDNAX Inc ::MEDNAX REPORTS SECOND QUARTER GAAP EPS OF $0.85; ADJUSTED EPS OF $1.07.SEES Q3 2018 ADJUSTED EARNINGS PER SHARE $0.94 TO $0.99.SEES Q3 2018 EARNINGS PER SHARE $0.72 TO $0.77.Q2 ADJUSTED EARNINGS PER SHARE $1.07.Q2 EARNINGS PER SHARE $0.85.Q2 REVENUE $916 MILLION VERSUS I/B/E/S VIEW $912.4 MILLION.Q2 SAME STORE SALES ROSE 3.2 PERCENT.BOARD AUTHORIZES SHARE REPURCHASE OF UP TO $500 MILLION.Q2 EARNINGS PER SHARE VIEW $1.06 -- THOMSON REUTERS I/B/E/S.VIVIAN LOPEZ-BLANCO HAS INFORMED MEDNAX OF HER INTENT TO RETIRE AS CHIEF FINANCIAL OFFICER OF THE COMPANY.MEDNAX - TO CONDUCT A FORMAL SEARCH FOR A SUCCESSOR, LOPEZ-BLANCO WILL REMAIN THROUGHOUT THE SEARCH PROCESS AND FOR A TRANSITIONAL PERIOD THEREAFTER.FOR Q3 2018, EXPECTS EBITDA GROWTH BETWEEN THREE PERCENT AND EIGHT PERCENT LOWER, COMPARED TO THE PRIOR-YEAR PERIOD EBITDA OF $151.5 MILLION.  Full Article

Court Rejects Mednax's Request To Stop Atrium Health's Transition To Scope Anesthesia
Monday, 25 Jun 2018 09:39am EDT 

June 25 (Reuters) - Atrium Health::ATRIUM HEALTH - COURT REJECTED MEDNAX'S REQUEST FOR PRELIMINARY INJUNCTION STOPPING CO'S TRANSITION TO SCOPE ANESTHESIA, ON JULY 1.  Full Article

Mednax Inc Reports Adjusted EPS Of $0.89
Monday, 30 Apr 2018 06:31pm EDT 

May 1 (Reuters) - MEDNAX Inc ::REPORTS ADJUSTED EPS OF $0.89.QTRLY EARNINGS PER SHARE $0.68.MEDNAX'S NET REVENUE FOR THREE MONTHS ENDED MARCH 31, 2018 INCREASED BY 7.9 PERCENT, TO $901.9 MILLION.SAME-UNIT REVENUE FROM NET REIMBURSEMENT-RELATED FACTORS INCREASED BY 2.1 PERCENT FOR 2018 Q1.FOR 2018 Q2, EXPECTS EARNINGS PER SHARE WILL BE IN A RANGE OF $0.81 TO $0.86 PER DILUTED SHARE.FOR 2018 Q2 EXPECTS ADJUSTED EPS WILL BE IN A RANGE OF $1.04 TO $1.09.FOR 2018 Q2, MEDNAX EXPECTS THAT EBITDA GROWTH WILL BE BETWEEN ONE PERCENT AND SIX PERCENT.OUTLOOK ASSUMES TOTAL SAME-UNIT REVENUE GROWTH FOR THREE MONTHS ENDED JUNE 30, 2018 WILL BE IN A RANGE OF TWO TO FOUR PERCENT.Q1 EARNINGS PER SHARE VIEW $0.86, REVENUE VIEW $903.6 MILLION -- THOMSON REUTERS I/B/E/S.Q2 EARNINGS PER SHARE VIEW $1.07 -- THOMSON REUTERS I/B/E/S.  Full Article

Chanos shorts Envision, says KKR may get cold feet on deal

NEW YORK Hedge fund manager Jim Chanos says he is betting that the stocks of physican practice management companies Mednax and Envision Healthcare will fall and said that private equity group KKR might get cold feet on a planned deal for Envision.